Solutions

Solara is a trial design selection platform that combines over 30 years of Cytel’s insight and advanced analytics expertise with the infinite power of cloud computing in a new platform that redefines clinical trial development. 

East Bayes provides easy access to complex Bayesian designs for all users. Cytel is bringing you East Bayes as a web-based extension of East for clinical trial design that blends the pace of SaaS delivery, the ease of use and robustness of Cytel software, and the velocity of cloud-based computing.

Cytel's software products not only help clients select empowered designs, they can also be used to manage and implement clinical studies. Cytel has over three decades of experience designing superior clinical trial technology.

Cytel’s suite of technology products for health economics outcomes research allows for access to evolving data in real time. Systematic literature reviews, HTA reports and other payer submission documents are generated in moments thanks to the enhanced human-machine partnership.

Cytel’s experts in Health Economic Outcomes Research generate evidence-based cost-effectiveness models that showcase the true economic value of your product. They specialize in health economic modeling, HEOR value communication, and other standard models of pharmaceutical modeling for comparative effectiveness research.

LiveSLR offers the efficiency of a machine with the knowledge of an expert, to ensure that every regulatory and payer submission contains the latest insights and discoveries.

Cytel’s experts in Real World Evidence use advanced quantitative techniques to prepare sponsors for regulatory submission and market access. They have supported reimbursement submissions in 26 countries across 40 indications, and draw on the experience of leading experts across the world.  

Randomized trials may not be feasible because of cost, ethics, feasibility, or time-constraints. Head-to-head comparisons utilize high-quality real-world datasets to provide evidence when RCTs are not feasible or augment evidence to provide another perspective.

The increased use of single arm trials in oncology and rare diseases to augment clinical trial submissions requires specialized statistical knowledge particular of Bayesian statistical methods. Cytel is one of the few trial design firms to receive regulatory acceptance of an SCA, accomplished using strategic Bayesian design techniques. 

Cytel’s experts in Global Health work with policy-makers, philanthropists and other geopolitical stakeholders to ensure that low- and middle-income countries (LMICs) benefits from the scientific developments in global biopharma.

Clinical trials with advanced innovative designs use adaptive methods, Bayesian methods and other novel clinical trial design techniques to increase efficiency and reduce costs.

Cytel's expert statisticians, data scientists and quantitative strategies will help you to reveal the full potential of your clinical studies. Prepare for submission with a strong quantitative data strategy.

Cytel’s methods driven technology and premier statistical expertise make Bayesian solutions more accessible to all pharmaceuticals and biotechs.

Solara combines over 30 years of Cytel’s insight and advanced analytics expertise with the infinite power of cloud computing in a new platform that redefines clinical trial development. 

Cytel’s end-to-end biometrics solutions encompass every stage of clinical development, helping sponsors seamlessly navigate the transition from design into study operations while safeguarding key components in SAP, eCRF design, data management plans, and programming deliverables.

With the goal of demonstrating safety and effectiveness of a therapy we expect the sponsor to insist that the clinical trial implementation team executes a trial with efficiency, precision and expertise.

At Cytel, we know that you entrust your Data Monitoring Committee (DMC) with a great deal of responsibility, often at the most critical stages of clinical development. We are here to protect the integrity of your clinical trial.

As a registered solutions provider of the Clinical Data Interchange Standards Consortium (CDISC), Cytel’s regulatory submissions teams are well-versed in the clinical data submission models that regulators are coming to expect in their clinical trial assessments.

Cytel takes pride in offering our clients access to teams that can act as extensions of a sponsor’s permanent staff. We bring a proven methodology that helps us identify, onboard and deploy talent to your team at both a local and global level, depending on your trial’s needs.

Cytel offers a full range of Data Management Services for clinical studies of all sizes, from Phase I – IV. Our industry experts seamlessly unify with your team to deliver on time projects, thoughtful database design, and a proactive approach to data cleaning.